The Technical Analyst
LifeStance Health Group, [LFST]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Care Facilities
LifeStance Health Group, Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
1.23% $5.76
America/New_York / 18 apr 2024 @ 13:35
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 2 192.77 mill |
| EPS: | -0.510 |
| P/E: | -11.29 |
| Earnings Date: | Apr 29, 2024 |
| SharesOutstanding: | 380.69 mill |
| Avg Daily Volume: | 1.343 mill |
| RATING 2024-04-18 |
|---|
| B |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Sell | |
| Return On Asset: | Neutral | |
| DE: | Buy | |
| P/E: | Strong Sell | |
| Price To Book: | Buy |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | ||||||
| Gr.Profit | ||||||
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -11.29 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.40x |
| Company: PE -11.29 | industry: PE 28.38 |
| DISCOUNTED CASH FLOW VALUE |
|---|
| N/A |
| N/A |
| Expected Trading Range (DAY) |
|---|
|
$ 5.43 - 6.10 ( +/- 5.88%) |
| ATR Model: 14 days |
Insider Trading
| Date | Person | Action | Amount | type |
|---|---|---|---|---|
| 2024-01-03 | Cipollone Paula | Sell | 3 369 | Common Stock |
| 2024-03-15 | Burdick Kenneth A | Sell | 214 605 | Common Stock |
| 2024-03-14 | Mullins Kevin Michael | Sell | 44 540 | Common Stock |
| 2024-03-14 | Pardo Ryan | Sell | 39 384 | Common Stock |
| 2024-03-12 | Deluca Teresa | Buy | 0 |
| INSIDER POWER |
|---|
| 62.02 |
| Last 95 transactions |
| Buy: 19 960 933 | Sell: 2 628 970 |
Forecast:
15:14 - $5.75
Live Trading Signals (every 1 min)
Forecast
1: 13:44 - $5.77
Forecast 2: 14:34 - $5.75
Forecast 3: 15:14 - $5.75
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $5.76 (1.23% ) |
| Volume | 0.376 mill |
| Avg. Vol. | 1.343 mill |
| % of Avg. Vol | 28.00 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For LFST
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 8 - 15:35 | sell | $6.44 | N/A | Active |
|---|
LFST
LifeStance Health Group, Inc., through its subsidiaries, provides outpatient mental health services. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy. It treats a range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder. In addition, the company operates outpatient mental health platform as well as offers patients care virtually through its online delivery platform or in-person at its centers in 32 states. It serves children, adolescents, adults, and geriatrics. LifeStance Health Group, Inc. was founded in 2017 and is based in Scottsdale, Arizona.
Latest Press Releases
2024-04-04 03:00:00 - Press Release
Investigation Alert: The Schall Law Firm Announces It Is Investigating Claims Against Lifestance Health Group, Inc. And Encourages Investors With Losses To Contact The Firm
Los angeles, ca / accesswire / april 4, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of lifestance health group, inc. ("lifestance" or "the company") (nasdaq:lfst) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
2024-03-20 03:00:00 - Press Release
Investor Action Notice: The Schall Law Firm Announces It Is Investigating Claims Against Lifestance Health Group, Inc. And Encourages Investors With Losses To Contact The Firm
Los angeles, ca / accesswire / march 20, 2024 / the schall law firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of lifestance health group, inc. ("lifestance" or "the company") (nasdaq:lfst) for violations of the securities laws. the investigation focuses on whether the company issued false and/or misleading statements and/or failed to disclose information pertinent to investors.
2024-03-12 09:00:00 - Press Release
Lifestance Appoints Dr. Teresa Deluca To Board Of Directors
Scottsdale, ariz. , march 12, 2024 /prnewswire/ -- lifestance health, one of the nation's largest providers of virtual and in-person outpatient mental healthcare, today announced that dr. teresa deluca has joined the company's board of directors.
2024-03-11 19:10:00 - Press Release
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Lifestance Health Group, Inc. - Lfst
New york , march 11, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of lifestance health group, inc. ("lifestance" or the "company") (nasdaq: lfst). such investors are advised to contact robert s.
2024-03-03 10:30:00 - Press Release
Shareholder Alert: Pomerantz Law Firm Investigates Claims On Behalf Of Investors Of Lifestance Health Group, Inc. - Lfst
New york , march 3, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of lifestance health group, inc. ("lifestance" or the "company") (nasdaq: lfst). such investors are advised to contact robert s.
Latest News
2024-02-28 14:33:03 - Seeking Alpha
LifeStance Health Group, Inc. (LFST) Q4 2023 Earnings Call Transcript
2024-02-28 08:16:04 - Zacks Investment Research
LifeStance Health Group (LFST) Reports Q4 Loss, Tops Revenue Estimates
LifeStance Health Group (LFST) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.09. This compares to loss of $0.13 per share a year ago.
2024-02-22 11:52:54 - InvestorPlace
Red Flag Alert: 3 Stocks That Hindenburg Research Is Shorting Now
Hindenburg Research may be the most famous activist short-selling investment research firm in recent history. Where many short sellers run their due diligence, develop a trade thesis and execute behind the scenes, Hindenburg is happy to bring ts research to wider market attention.
2024-02-07 16:10:00 - GlobeNewsWire
LifeStance to Host Fourth Quarter and Full Year 2023 Earnings Conference Call on February 28, 2024
SCOTTSDALE, Ariz., Feb. 07, 2024 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its fourth quarter and full year 2023 earnings release before the market opens on Wednesday, February 28, 2024.
2024-02-05 09:06:06 - Zacks Investment Research
LifeStance Health (LFST) Soars 6.6%: Is Further Upside Left in the Stock?
LifeStance Health (LFST) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
2023-11-11 04:29:06 - Seeking Alpha
LifeStance Health Group, Inc. (LFST) Q3 2023 Earnings Call Transcript
LifeStance Health Group, Inc. (NASDAQ:LFST ) Q3 2023 Earnings Conference Call November 8, 2023 8:30 AM ET Company Participants Monica Prokocki - Vice President, Investor Relations Ken Burdick - Chief Executive Officer Dave Bourdon - Chief Financial Officer Danish Qureshi - Chief Operating Officer Conference Call Participants Craig Hettenbach - Morgan Stanley Lisa Gill - JP Morgan Jack Senft - William Blair Kevin Caliendo - UBS Jamie Perse - Goldman Sach Brian Tanquilut - Jefferies Gary Taylor - TD Cowen Operator Ladies and gentlemen, Thank you for standing by. My name is Desiree, and I will be your conference operator today.
2023-11-01 11:17:28 - Zacks Investment Research
Will LifeStance Health Group (LFST) Report Negative Earnings Next Week? What You Should Know
LifeStance Health (LFST) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
2023-10-18 16:10:00 - GlobeNewsWire
LifeStance to Host Third Quarter 2023 Earnings Conference Call on November 8, 2023
SCOTTSDALE, Ariz., Oct. 18, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, will issue its third quarter earnings release before the market opens on Wednesday, November 8, 2023.
2023-09-21 16:10:00 - GlobeNewsWire
LifeStance to Present at the 7th Annual Bernstein Healthcare Services Disruptors Conference
SCOTTSDALE, Ariz., Sept. 21, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 7th Annual Bernstein Healthcare Services Disruptors Conference, which will be hosted in New York City, NY.
2023-08-28 16:10:00 - GlobeNewsWire
LifeStance to Present at the 21st Annual Morgan Stanley Healthcare Conference
SCOTTSDALE, Ariz., Aug. 28, 2023 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (NASDAQ: LFST), one of the nation's largest providers of outpatient mental health care, today announced that management will present at the upcoming 21st Annual Morgan Stanley Global Healthcare Conference, which will be hosted in New York City, NY.